Here in this study, chemotherapy and cancer vaccine (one several types of immunotherapy strategies) were combined to clinically treat ovarian cancer patients. Up to 60% of patients showed clinical benefit from this therapy. Although this therapeutic strategy is still in test phase, scientists of this study believe that this therapy could be beneficial as there is enough scientific and clinical evidence accumulated showing the likelihood of its success.
Dr. Ayguen Sahin
To read more, go to: http://www.medicalnewstoday.com/articles/270772.php